Arca
Skip to content
Tools
Tools

GRM3: Metabotropic glutamate receptor 3

G protein-coupled receptor for glutamate.

  • Drugs that act on it: 4
  • Approved: 0
  • In phases 1 to 3: 4
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on GRM3, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3
  • Other 1

Approved0

    Phase 31

    Phase 21

    • Decoglurant

    Phase 12

    • LY2969822
    • LY404039

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    • Denovo Biopharma LLC125%

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 3 of 4 act as: Metabotropic glutamate receptor 3 agonist; the rest name their own mechanism.
    Pomaglumetad methionil anhydrousPhase 3Denovo Biopharma LLCSmall moleculeAgonist0
    DecoglurantPhase 2RocheSmall moleculeModulatorMetabotropic glutamate receptor 3 modulator0
    LY2969822Phase 1—OtherAgonist0
    LY404039Phase 1—Small moleculeAgonist0

    Diseases most associated with it

    Open Targets association score, 0 to 1; all associations
    • Hearing loss disorder0.49
    • Mathematical ability0.43
    • Neurotic disorder0.42
    • Abnormality of the skeletal system0.41
    • Smoking initiation0.39
    • Intelligence0.33

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2888, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt Q14832, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.